Clinical Trials Saved My Life
By Mara Klecker When Barbara Hunter found out her melanoma had returned as Stage IV and was in her liver,…
Blog - Melanoma360
01/02/2024
Clinical Trials Saved My Life
By Mara Klecker When Barbara Hunter found out her melanoma had returned as Stage IV and was in her liver,…
|
12/19/2023
Navigating Melanoma During the Holidays
The holiday season is often portrayed as a time of joy, love, and celebration. However, for melanoma cancer patients, it…
|
12/18/2023
The Clinical Trial Experience: A Patient’s Perspective
In 2010, Mary Elizabeth Williams was diagnosed with metastatic melanoma. The following year, she was offered the opportunity to participate…
|
12/05/2023
Celebrate Survivorship – Give Towards Melanoma Research
Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
|
11/14/2023
Melanoma Cancer and Financial Toxicity
While being diagnosed with cancer alone can put a person under tremendous amounts of mental and emotional stress, the additional…
|
10/31/2023
National Family Caregiver Month
National Caregiver Month is observed every November to honor and appreciate the selfless individuals who dedicate their lives to caring…
|
10/23/2023
Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial Published: Oct 21, 2023 Data published in New…
|
|
10/15/2023
Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
|
|
10/13/2023
That Good Night: Life and Medicine in the Eleventh Hour
A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
|
09/17/2023
Notes from the Lab: Novel targets for immune checkpoint inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
|
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026